These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 552898)

  • 21. [Gluconeogenesis during therapy of experimental tumors with hydrazine sulfate].
    Filov VA; Burova TM
    Biull Eksp Biol Med; 1984 Jan; 97(1):73-4. PubMed ID: 6692028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antitumor activity and pharmacological properties of furizil].
    Stukov AN; Kraĭz BO; Aleksandrov VA; Ivin BA; Filov VA
    Vopr Onkol; 1985; 31(5):52-4. PubMed ID: 4013130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potentiation of antitumor and antimetastatic activities of alpha-difluoromethylornithine by interferon inducers.
    Sunkara PS; Prakash NJ; Rosenberger AL; Hagan AC; Lachmann PJ; Mayer GD
    Cancer Res; 1984 Jul; 44(7):2799-802. PubMed ID: 6426786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition by hydrazine sulfate and various hydrazides, of in vivo growth of Walker 256 intramuscular carcinoma, B-16 melanoma, Murphy-Sturm lymphosarcoma and L-1210 solid leukemia.
    Gold J
    Oncology; 1973; 27(1):69-80. PubMed ID: 4739164
    [No Abstract]   [Full Text] [Related]  

  • 25. [Studies in vivo and in vitro on the influence of 5-fluorouracil and n'-(2'-furanidyl)-5-fluorouracil on the walker carcinosarcoma 256 in the rat (author's transl)].
    Mattern J; Volm M; Wayss K; Weber N
    Arzneimittelforschung; 1980; 30(6):981-4. PubMed ID: 6774738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Augmentation of the effect of doxorubicin with low-dose tumor necrosis factor in experimental liver metastasis.
    Bloom ND; Norbergs DA; Sherman B; Sadjadi M; Ramaswamy G; Jacobs R; Ackerman N
    Mol Biother; 1990 Jun; 2(2):121-4. PubMed ID: 2363856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical chemotherapy of intradermal Walker 256 carcinosarcoma with diaziquone and doxorubicin in the rat.
    Moore DJ; Powis G; Richardson RL; Pittelkow MR
    Cancer Res; 1985 Nov; 45(11 Pt 1):5466-72. PubMed ID: 4053022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative studies of clinically equivalent doses of various cytostatic agents on the mouse Ehrlich ascites carcinoma and rat Walker carcinosarcoma 256 in vivo and in cell culture (in vitro)].
    Matthias M; Tanneberger S; Gummel H
    Arch Geschwulstforsch; 1970; 36(3):240-6. PubMed ID: 5498278
    [No Abstract]   [Full Text] [Related]  

  • 29. On the relationship between the activity of acetylation, growth of experimental tumors and efficacy of their suppression by hydrazine sulphate.
    Dilman VM; Anisimov VN; Kolosov AI; Bulovskaya LN
    Oncology; 1976; 33(5-6):219-21. PubMed ID: 1026855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Carbonyl derivatives of tilorone. Part 2: On the cancerostatic activity of carbonyl derivatives of tilorone (author's transl)].
    Schulze W; Letsch G; Gutsche W; Jungstand W; Wohlrabe K
    Pharmazie; 1979 Apr; 34(4):216-21. PubMed ID: 482327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the selectivity of antitumor agents.
    Garattini S; Guaitani A; Nanni E; Palma V
    Cancer Res; 1967 Dec; 27(12 Pt 2):1309-437. PubMed ID: 4295303
    [No Abstract]   [Full Text] [Related]  

  • 32. [Screening of substances and extracts of plant origin in Walker carcinosarcoma 256].
    Sampaio MR; De Oliveira MM
    An Acad Bras Cienc; 1975; 47(1):149-53. PubMed ID: 1233885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The antitumor effects of the quinoline-3-carboxamide linomide on Dunning R-3327 rat prostatic cancers.
    Ichikawa T; Lamb JC; Christensson PI; Hartley-Asp B; Isaacs JT
    Cancer Res; 1992 Jun; 52(11):3022-8. PubMed ID: 1591718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Characteristics of growth and sensitivity to cytostatics of Walker 256 carcinosarcoma in randombred and Wistar rats].
    Karaivanova MK
    Eksp Med Morfol; 1974; 13(4):237-42. PubMed ID: 4219353
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical data on the antitumor activity of hydrazine sulfate.
    Gershanovich ML; Danova LA; Kondratyev VB; Malyugina LL; Stukov AN; Seitz JF; Filov VA
    Cancer Treat Rep; 1976 Jul; 60(7):933-5. PubMed ID: 1009524
    [No Abstract]   [Full Text] [Related]  

  • 36. Synergistic in vivo antitumor effect of the histone deacetylase inhibitor MS-275 in combination with interleukin 2 in a murine model of renal cell carcinoma.
    Kato Y; Yoshimura K; Shin T; Verheul H; Hammers H; Sanni TB; Salumbides BC; Van Erp K; Schulick R; Pili R
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4538-46. PubMed ID: 17671140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Some characteristics of the biological action of D, L-1,4-dibromo-1,4-dideoxy-2,3-butanediol].
    Miuller NR; Remizov AL; Belogorodskiĭ VV; Filov VA
    Farmakol Toksikol; 1975; 38(5):590-1. PubMed ID: 1191387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antineoplastic agents. 41. The beetle Allomyrina dichotomus.
    Pettit GR; Ode RH
    Lloydia; 1976; 39(2-3):129-33. PubMed ID: 948237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor effect of laticifer proteins of Himatanthus drasticus (Mart.) Plumel - Apocynaceae.
    Mousinho KC; Oliveira Cde C; Ferreira JR; Carvalho AA; Magalhães HI; Bezerra DP; Alves AP; Costa-Lotufo LV; Pessoa C; de Matos MP; Ramos MV; Moraes MO
    J Ethnopharmacol; 2011 Sep; 137(1):421-6. PubMed ID: 21679758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies with 3H-labeled methylhydrazine derivatives].
    Kleibel F
    Nucl Med (Stuttg); 1965; 2():63-7. PubMed ID: 5888981
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.